Elucid

399 Boylston Street, Suite 400, Boston, MA 02116  All United States companies → — Founded 2013
Imaging AI Specialist Specialty-Focused AI
Series D

Products

ElucidVivo A.3
Elucid
Cardiology AI
ElucidVivo A. It assists physicians in atherosclerosis patient stratification and optimizes treatment decisions by offering detailed visualization and measurement of plaque characteristics validated against histology.

See all 1 product →

About Elucid

Elucid is a medical technology company that develops AI to identify subtle indicators of cardiovascular risk. The company’s mission is to predict and personalize the prevention of heart attacks and strokes by providing a more precise view of atherosclerosis, the underlying cause of cardiovascular disease. Elucid’s clinical platform aims to help physicians deliver CCTA-guided personalized care.

Elucid’s platform transforms CT images into a dynamic, interactive map of disease, offering detailed analysis of patients’ atherosclerotic disease. This enables physicians to personalize care based on individual patient anatomy. The company’s offerings include Plaque-IQ™, a CT-based plaque analysis indicated for both coronary and carotid anatomies, and BioIntegrated FFR-CT, which is concordant with plaque results.

Focus Areas

cardiovascular disease AI-powered imaging analysis plaque characterization fractional flow reserve personalized medicine atherosclerosis coronary artery disease stroke prevention

Business Intelligence

TechnologyAI-powered software-as-a-service (SaaS) platform, cloud and on-premise secure deployment, machine learning/neural networks for image tissue classification, 3D segmentation and visualization, DICOM integration and PACS/EMR interoperability

What Physicians Need to Know

AI-Powered Imaging Analysis
Elucid develops AI to see invisible features of cardiovascular risk, transforming CT images into a dynamic, interactive map of disease. Their platform provides a precise view of atherosclerosis, the root cause of cardiovascular disease.
Plaque Characterization
Elucid's PlaqueIQ™ is a non-invasive CT plaque analysis indicated for both coronary and carotid anatomies. It offers histology-validated plaque analysis, including the identification of lipid-rich necrotic core (LRNC), which is a strong predictor of heart attack and stroke.
Fractional Flow Reserve (FFR-CT)
Elucid provides BioIntegrated FFR-CT that is concordant with plaque results. Their FFR-IQ™ software has received FDA clearance and demonstrated 93% accuracy with strong performance in the 'gray zone'.
Personalized Medicine
The Elucid platform enables patient-specific treatment pathways by providing lesion-level plaque composition analysis and clinical insights. This empowers physicians to deliver personalized cardiovascular care based on a patient's individual anatomy and disease characteristics.
Atherosclerosis and Coronary Artery Disease
Elucid's technology focuses on providing a more precise view of atherosclerosis, the root cause of cardiovascular disease. By characterizing specific types of high-risk plaques, the platform helps identify patients at risk of myocardial infarction.
Stroke Prevention
Elucid's PlaqueIQ™ image analysis software is used for the carotid arteries, allowing for the characterization of plaque composition to revolutionize carotid stroke risk assessment. This helps in identifying patients at highest risk for carotid stroke and facilitates procedural choice and planning.
Key Differentiators
Elucid's key differentiators include PlaqueIQ™ being the first and only CT-based plaque analysis indicated for both coronary and carotid anatomies, its histology-validated plaque analysis including LRNC, and BioIntegrated FFR-CT that is concordant with plaque results. The platform offers unmatched accuracy, reproducibility, and transparency.
Technology Stack
The technology stack includes AI-powered image analysis for CT scans, specifically designed for non-invasive plaque analysis and BioIntegrated FFR-CT. The platform integrates a user interface for clinical insights.
Physician Tip

Elucid's platform provides detailed, lesion-level plaque composition analysis, including the identification of lipid-rich necrotic core, which is crucial for understanding a patient's disease process beyond overall plaque metrics. This insight, combined with BioIntegrated FFR-CT, supports more informed clinical decision-making and enables personalized treatment pathways for both coronary and carotid arteries. The ability to characterize plaque composition precisely revolutionizes stroke risk assessment, superseding traditional stenosis assessment for more accurate identification of high-risk patients.

Products by Elucid

1 product in the directory

ElucidVivo A.3
Elucid
Cardiology AI
ElucidVivo A. It assists physicians in atherosclerosis patient stratification and optimizes treatment decisions by offering detailed visualization and measurement of plaque characteristics validated against histology.

Videos

News, demos, and interviews about Elucid.

Loading videos...

Videos load interactively. If none appear, search YouTube for Elucid →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Elucid PlaqueIQ™ is a non-invasive CT plaque analysis platform indicated for both coronary and carotid anatomies. It quantifies lesion-level plaque composition, including lipid-rich necrotic core, from CT scans.
Elucid's platform provides histology-validated plaque analysis, BioIntegrated FFR-CT, and stenosis information to help physicians deliver personalized cardiovascular care based on detailed atherosclerotic disease analysis.
BioIntegrated FFR-CT is a component of Elucid's platform that is concordant with plaque results, recognizing that plaque composition affects vessel performance.
Elucid's technology is designed for cardiologists, radiologists, and vascular specialists to identify high-risk atherosclerotic disease.
The platform helps characterize plaque composition in carotid arteries, which is a critical risk element for stroke, allowing for more accurate identification of high-risk patients.

Investors

Who's funded Elucid.

Related Companies

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Siemens Healthineers is a leading global medical technology company that pioneers breakthroughs in healthcare. The company focuses on medical technology and diagnostics, offering a wide range of products including imaging systems, laboratory diagnostics, and advanced therapies. Their innovations aim to improve patient outcomes and make healthcare more accessible and sustainable. Siemens Healthineers has a strong […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.